About: A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im April 2000 veröffentlicht worden isch (gsw) im April 2000 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована у 2000 (uk) article scientifique publié en avril 2000 (fr) artículu científicu espublizáu n'abril de 2000 (ast) scientific article published on 01 April 2000 (en)
publication date	wds:Q61651052-158E1751-9B91-445F-8606-32E25326D1E1
publication date	2000-04-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q61651052-5A8EA9D8-439C-491B-B36D-6DDAB2BC6AB2
exact match	https://scigraph.springernature.com/pub.10.1023/a:1005431323945
cites work	wds:Q61651052-024B73FB-15DD-44A5-A3C5-1F4B140F37C6 wds:Q61651052-03BFB445-E118-4584-B013-933D4311F59A wds:Q61651052-18312F9C-572F-4F8A-8A8C-87CB286C3A0A wds:Q61651052-1A5E465F-1DC4-4BC1-A598-A18F3C46ACC3 wds:Q61651052-20E98C1C-2362-4538-B9DD-D620D1B4BA9A wds:Q61651052-2336FA48-0F74-4530-B7DF-C39558B6A0D8 wds:Q61651052-30DE0236-5D92-4319-B98A-09664DA2CC08 wds:Q61651052-31FC04B4-44E6-4C85-8AD8-C2EB4B92E507 wds:Q61651052-3885566F-AF11-427A-B07C-41CDBE7EAE6B wds:Q61651052-40C04EB9-795E-4DE5-86C6-36F0923E56D6 wds:Q61651052-463B1CFA-7CF9-4401-8609-1257E02DC3DB wds:Q61651052-4AAAA05C-0F1E-47D8-BFDF-3D1DD3877793 wds:Q61651052-4E4204AD-B6BB-4B52-A50E-C9C335933102 wds:Q61651052-6D85FC86-4B0B-4FB5-9209-A6A5CCCCE5B0 wds:Q61651052-713FBE43-33D7-4FEE-95BD-CAC3CF3D5F0D wds:Q61651052-8036CC25-796F-4089-ABA4-6A188BEF4FC5 wds:Q61651052-83E5BEE9-7AFF-4307-93C7-C1FEBF67ECDF wds:Q61651052-850A040D-6931-4BF9-9862-E49480993D4B wds:Q61651052-88B23C6B-545A-4193-9B44-037AF1A516C5 wds:Q61651052-8F68BD39-5CD6-4496-99D5-B2CB413D1F0B wds:Q61651052-97DE2501-A8E2-4DE9-A5FB-15498A7ADC33 wds:Q61651052-ABC81EB9-31CB-4E55-A152-51373C8DBD05 wds:Q61651052-AC1149E9-EC4B-463D-9805-FA7BA25F3B73 wds:Q61651052-B2F5E451-5483-4B74-BA3D-43429C97D548 wds:Q61651052-B37DE41F-7A85-4999-8A25-565ACCE5D545 wds:Q61651052-C4F69F95-EB28-485D-BCFF-8AE7879D8B45 wds:Q61651052-DB316C9E-5481-460E-9964-8C58CD6A2FB7 wds:Q61651052-F6C7D893-E079-4307-B505-1DC2250DA736 wds:Q61651052-F7E8717B-BA43-49E0-B962-48243651CBD4
cites work	Classification of chronic viral hepatitis: a need for reassessment A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg The development of cirrhosis in patients with chronic type B hepatitis: A prospective study Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. An improved approximate formula for calculating sample sizes for comparing two binomial distributions Natural history and prognostic factors for chronic hepatitis type B Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus Analysis of serial measurements in medical research Thymus therapy for cancer? A criteria-based, systematic review Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B Thymic hormones--a clinical update Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection Clinical applications of thymosin alpha-1 Low Thymosin Alpha-1 Concentrations in Patients Chronically Infected with the Hepatitis B Virus* Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. A pilot study of thymosin-alpha 1 therapy for chronic hepatitis D Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B
author name string	wds:Q61651052-350DB95F-EDD4-458D-BC71-F76061271E59 wds:Q61651052-43E989EB-B5AE-4389-9818-36D152C1D285 wds:Q61651052-740922E1-795D-4947-91B4-3266D08FA0A2 wds:Q61651052-88D7B48C-CF66-4143-8864-ABAE187CE286 wds:Q61651052-9B4552DC-BBBD-4B26-B131-C1C9644C39C7 wds:Q61651052-9C4450EB-5225-4019-80FD-A6560D0D9FF8 wds:Q61651052-AC54F8E0-A1CF-44EB-B42E-E6110FBB028D
author name string	S Tempini J S Franzone R Severini G Ideo C Zavaglia A Airoldi G Bettale
rdfs:label	A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (en) A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (nl)
skos:prefLabel	A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (en) A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (nl)
name	A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (en) A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (nl)
author	wds:Q61651052-1CE57805-0231-46E9-8E4C-937AD33A7715
author	Carmine Tinelli
title	wds:Q61651052-5895A4A7-CB4C-4DEA-94C2-5946888AF92A
title	A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B (en)
page(s)	wds:Q61651052-97B41409-18D7-4B13-B6F4-38A1260004AE
page(s)	690-696
instance of	wds:Q61651052-5201923E-AD7D-4018-B1E6-D42AA8F7740B
instance of	scholarly article
main subject	wds:Q61651052-3E4B8236-9E08-4A49-8FA8-685ED9ED8B21
main subject	chronic hepatitis B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software